Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharma Mar presents phase I findings for ecteinascidin 743 at scientific forum

Oct. 1, 1999

Cell Genesys enters cancer gene therapy collaboration with Rigel

Oct. 1, 1999

Texas A&M describes important new class of agents for breast cancer

Sep. 30, 1999

New antitumor compounds from Schering-Plough act by inhibiting protein farnesyltransferase

Sep. 30, 1999

Long-term efficacy and tolerability reported for MTX-HSA in preliminary clinical testing

Sep. 30, 1999

Northwest Biotherapeutics and Battelle form prostate cancer collaboration

Sep. 30, 1999

Cell Pathways and RPR to study Aptosyn in combination with Taxotere

Sep. 30, 1999

Hybridon presents HYB-165, the first orally active antitumor oligonucleotide

Sep. 30, 1999

EntreMed's first phase I study of Endostatin now enrolling patients

Sep. 29, 1999

IntraDose featured in several ECCO 10 presentations; clinical results consistently positive

Sep. 29, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...